AIT (allergen immunotherapy): A model for the "precision medicine"

被引：25

作者：

Passalacqua G. ^{[1
]}

Canonica G.W. ^{[1
]}

机构：

[1] IRCCS San Martino-IST-University of Genoa, Allergy and Respiratory Diseases, Department of Internal Medicine, S. Martino Hospital, Pad.Maragliano, L.go R Benzi 10, Genoa

来源：

Clinical and Molecular Allergy | / 13卷 / 1期

关键词：

Allergen immunotherapy; Personalized medicine; Precision medicine;

D O I：

10.1186/s12948-015-0028-6

中图分类号：

学科分类号：

摘要：

The interpretation of medical approaches, especially therapy, evolved rapidly in the last century. Starting from the simple description of symptoms, we moved to the pathophysiological descriptions, to the evidence-based medicine, until the so-called "precision medicine". This latter can be defined as a structural model aimed at customizing healthcare, with medical decisions/products tailored on an individual patient at a highly detailed level. In this sense, allergen immunotherapy represents an optimal model of "precision medicine", since we know and describe symptoms, function, aetiological agents at molecular level, and we have the possibility to intervene on the natural history of the disease. If considered under the point of view of pharmaco-economy, that is prescribing the optimal treatment to the right patient, allergen immunotherapy represents an almost-ideal model of precision medicine. © 2015 Passalacqua and Canonica.

引用

共 30 条

[1]

Émile Littré: Oeuvres Completes (Traduction Nouvelle, avec le texte grec en regard), 1, (1839)

[2]

Harvey W., Exercitatio Anatomica de Motu Cordis et Sanguinis in animalibus, (1628)

[3]

Virchow R.K., Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebenlehre, (1858)

[4]

Lister J., Antiseptic principle in the practice of surgery, Br Med J, 2, 5543, pp. 9-12, (1967)

[5]

Brasier A.R., Identification of innate immune response endotypes in asthma: implications for personalized medicine, Curr Allergy Asthma Rep, 13, pp. 462-468, (2013)

[6]

Agache I.O., From phenotypes to endotypes to asthma treatment, Curr Opin Allergy Clin Immunol, 13, pp. 249-256, (2013)

[7]

Bieber T., Stratified medicine, (2013)

[8]

Braido F., Holgate S., Canonica G.W., From "Blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providers, Pulm Pharmacol Ther, 25, (2012)

[9]

Fuchs V.R., The gross domestic product and health care spending, N Engl J Med, 369, 2, pp. 107-109, (2013)

[10]

Hamburg M.A., Collins F.S., The path to personalized medicine, N Engl J Med, 363, pp. 301-304, (2010)

← 1 2 3 →